1. Home
  2. HOTH vs CMAX Comparison

HOTH vs CMAX Comparison

Compare HOTH & CMAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HOTH
  • CMAX
  • Stock Information
  • Founded
  • HOTH 2017
  • CMAX 2011
  • Country
  • HOTH United States
  • CMAX United States
  • Employees
  • HOTH N/A
  • CMAX N/A
  • Industry
  • HOTH Biotechnology: Pharmaceutical Preparations
  • CMAX Computer Software: Prepackaged Software
  • Sector
  • HOTH Health Care
  • CMAX Technology
  • Exchange
  • HOTH Nasdaq
  • CMAX Nasdaq
  • Market Cap
  • HOTH 7.6M
  • CMAX 7.2M
  • IPO Year
  • HOTH 2019
  • CMAX N/A
  • Fundamental
  • Price
  • HOTH $0.82
  • CMAX $1.69
  • Analyst Decision
  • HOTH Strong Buy
  • CMAX Hold
  • Analyst Count
  • HOTH 4
  • CMAX 1
  • Target Price
  • HOTH $4.75
  • CMAX $6.40
  • AVG Volume (30 Days)
  • HOTH 996.3K
  • CMAX 787.8K
  • Earning Date
  • HOTH 11-12-2024
  • CMAX 11-26-2024
  • Dividend Yield
  • HOTH N/A
  • CMAX N/A
  • EPS Growth
  • HOTH N/A
  • CMAX N/A
  • EPS
  • HOTH N/A
  • CMAX N/A
  • Revenue
  • HOTH N/A
  • CMAX $784,551,000.00
  • Revenue This Year
  • HOTH N/A
  • CMAX $13.01
  • Revenue Next Year
  • HOTH N/A
  • CMAX $32.42
  • P/E Ratio
  • HOTH N/A
  • CMAX N/A
  • Revenue Growth
  • HOTH N/A
  • CMAX 9.06
  • 52 Week Low
  • HOTH $0.58
  • CMAX $1.18
  • 52 Week High
  • HOTH $1.73
  • CMAX $30.00
  • Technical
  • Relative Strength Index (RSI)
  • HOTH 42.93
  • CMAX 43.35
  • Support Level
  • HOTH $0.83
  • CMAX $1.63
  • Resistance Level
  • HOTH $0.90
  • CMAX $1.81
  • Average True Range (ATR)
  • HOTH 0.09
  • CMAX 0.31
  • MACD
  • HOTH -0.01
  • CMAX -0.02
  • Stochastic Oscillator
  • HOTH 10.18
  • CMAX 21.93

About HOTH Hoth Therapeutics Inc.

Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.

About CMAX CareMax Inc.

CareMax Inc is a technology-enabled care platform providing value-based care and chronic disease management to seniors. It operates various owned medical centers that offer a comprehensive suite of healthcare and social services and a proprietary software and services platform that provides data, analytics, and rules-based decision tools/workflows for physicians across the United States.

Share on Social Networks: